EAM Investors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

EAM Investors’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,274	Closed	-$2.88M	–	391
2015 Q1	$2.88M	Buy	+1,274	New	+$2.17M	0.33%	159
2014 Q1	–	Sell	-356	Closed	-$762K	–	368
2013 Q4	$762K	Buy	+356	New	+$842K	0.14%	302

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

EAM Investors's AMPE Position: Q2 2015 in Review

EAM Investors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 1,274 shares — an estimated $2.88M sold.

EAM Investors first reported a position in AMPE in Q4 2013 and held it in 2 quarters. The position peaked at $2.88M in Q1 2015. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

EAM Investors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
EAM Investors sold 1,274 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $2.88M.
EAM Investors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 2 quarters.
EAM Investors's Ampio Pharmaceuticals Inc. position peaked at $2.88M in Q1 2015.
64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on EAM Investors's 13F filing for Q2 2015, filed 13 Aug 2015.